Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Infections, Meningococcal: full-pipeline trial registry
A small indexed set (8 trials) with no open enrollment listed right now.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · none currently recruiting · #2,176 of 28,707 conditions by registered trial count
Infections, Meningococcal: 8 US clinical trials tracked, none currently recruiting.
Infections, Meningococcal is the subject of 8 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 2 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is GlaxoSmithKline, running 8 of these trials.
Enrollment posture brief
Registry condition infections-meningococcal
OPEN 0 | RECR 0% | LATE 2 | EARLY 3 | RANK #2176 | SPON 8
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Infections, Meningococcal has no open enrollment in this registry pull (8 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Infections, Meningococcal on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Infections, Meningococcal is recruiting below its size-band peers.
0 of 8 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Infections, Meningococcal research.
GlaxoSmithKline accounts for 8 of 8 trials (100%). 1 distinct sponsors appear on at least one study for this condition label.
-
Typical Infections, Meningococcal enrolment sits around 385 participants.
Median target enrolment is 385 among the 8 trials that report a genuine target (sentinel values excluded). 3 of those (37.5%) plan for fewer than 100 participants.
-
Infections, Meningococcal splits between interventional and observational designs.
5 interventional and 3 observational studies make up this index (62.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Indexed trials (enrollment closed)
8 total, page 1 of 1
Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014
GlaxoSmithKline
NCT00614614
Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine GSK 134612 Versus Menactra® in Healthy Adolescents/Adults
GlaxoSmithKline
NCT01165242
The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Toddlers
GlaxoSmithKline
NCT00718666
Immunogenicity and Safety of Meningococcal Vaccine GSK134612 Given as 1 or 2 Doses to Healthy 9-12 Months Old Toddlers.
GlaxoSmithKline
NCT00471081
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Infant Study
GlaxoSmithKline
NCT02287688
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
GlaxoSmithKline
NCT02223637
Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects
GlaxoSmithKline
NCT01641042
Safety of 4CMenB Exposure During Pregnancy
GlaxoSmithKline
NCT02640677
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Infections, Meningococcal records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Infections, Meningococcal trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Infections, Meningococcal page
8 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Infections, Meningococcal trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- GlaxoSmithKline sponsors the most Infections, Meningococcal trials on record, review their full trial history before evaluating a specific study. See GlaxoSmithKline's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Infections, Meningococcal condition card totals 8 registered trials; most-linked intervention Meningococcal vaccine GSK134612; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.